Celgene Corp (CELG) 105.14 $CELG
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed
at The Street - 1 hr ago
With the Federal Reserve finally ending its bond buying, there are many stocks that are ready to be bought, not sold, on any Fed-induced weakness, Cramer says.
KMI: 38.33 (-0.84), ETN: 65.92 (+1.14), FB: 75.86 (-4.91), PFE: 29.49 (+0.40), INVN: 16.08 (-5.40), WDC: 95.79 (+2.71), HPQ: 35.38 (-0.16), CVRR: 24.51 (-0.31), CELG: 105.14 (-0.56), EPB: 40.36 (-0.86), ISIS: 45.01 (-1.42), IBM: 163.46 (-0.14), AMAT: 21.47 (+0.22), GOOGL: 558.45 (-0.49), TWTR: 42.08 (-1.70), MSFT: 46.62 (+0.13), IGT: 16.29 (unch), REGN: 387.70 (-10.19), PII: 148.31 (-1.26), BABA: 98.31 (-1.37)
Final Glance: Biotechnology companies
AP - Wed Oct 29, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Midday Glance: Biotechnology companies
AP - Wed Oct 29, 12:41PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 29, 11:28AM CDT
Quite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
BIIB: 315.06 (-2.97), CBST: 71.35 (-0.99), MDCO: 25.16 (-0.70), SRPT: 15.19 (+0.07), ALXN: 190.49 (-1.71), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Early Glance: Biotechnology companies
AP - Wed Oct 29, 9:53AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 2.54% Gain
Comtex SmarTrend(R) - Tue Oct 28, 3:59PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 105.14 (-0.56)
After Yesterday's Rally of 2.54% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 28, 3:58PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 105.14 (-0.56)
Stocks Extend Gains As Alibaba, Tesla Rally
at Investor's Business Daily - Tue Oct 28, 11:04AM CDT
Major averages extended their gains in late-morning trading amid earnings reports and a surprisingly strong consumer confidence reading. The Nasdaq rallied 1.2%, the S&P 500 gained 0.6% and the Dow was up 0.4%. Volume was tracking higher on the...
TSLA: 238.10 (-4.67), AMGN: 158.88 (+1.69), AAPL: 107.34 (+0.60), BABA: 98.31 (-1.37), CELG: 105.14 (-0.56)
Can Celgene Corporation Stock Motor to $150 Following Earnings?
Sean Williams, The Motley Fool - Motley Fool - Tue Oct 28, 7:03AM CDT
Just as the proverbial American worker stamps their time card on a daily basis and does their job, biotech giant Celgene continues to deliver for shareholders without fail. Last Thursday, Celgene dazzled investors yet again by reporting better...
OMED: 21.95 (-0.13), AGIO: 79.36 (-1.24), CELG: 105.14 (-0.56)
Amgen Beats Earnings Estimates, What's Next for AMGN? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Oct 27, 11:59PM CDT
Amgen had a solid beat on earnings, and AMGN stock was rising after hours.
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Four Biotechs Lead Health Care Stocks In Big Cap 20
at Investor's Business Daily - Mon Oct 27, 6:00PM CDT
Medical stocks are flexing their muscles in the latest Big Cap 20 list, as they've more than doubled in number from the prior week. Even though a few medical sectors make the cut, biotechs are well represented. The group earned the top ranking in...
VRX: 129.76 (-1.31), ALXN: 190.49 (-1.71), ILMN: 188.88 (-1.77), AMGN: 158.88 (+1.69), REGN: 387.70 (-10.19), CELG: 105.14 (-0.56)
Forget MannKind Corporation: 3 Better Stocks
Motley Fool Staff - Motley Fool - Mon Oct 27, 8:13AM CDT
Source: MannKind. A doubling of Americans diagnosed with diabetes over the coming decade may support demand for MannKind 's inhalable insulin Afrezza, but that doesn't necessarily mean that MannKind is biotech's best idea. We asked three of...
DXCM: 44.50 (+0.34), NVAX: 5.41 (-0.07), AGIO: 79.36 (-1.24), SNY: 45.22 (-2.85), MNKD: 6.07 (-0.11), CELG: 105.14 (-0.56)
3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
Todd Campbell, The Motley Fool - Motley Fool - Mon Oct 27, 7:03AM CDT
Source: Celgene. Gilead Sciences has captured investors' attention this year thanks to wildly impressive sales of its hepatitis C drug Sovaldi, but the company is by no means the only fast-growing big biotech out there. Gilead's bottom line...
MDVN: 99.55 (-1.63), JNJ: 105.56 (+0.77), BIIB: 315.06 (-2.97), GILD: 110.72 (-2.73), NVS: 91.31 (-1.04), CELG: 105.14 (-0.56)
IBD 50 Stocks Regain Buy Points
at Investor's Business Daily - Fri Oct 24, 5:54PM CDT
The IBD 50 has been the land of the second chance, as many stocks have rebounded from sell signals. In several cases, stocks triggered the 8% sell rule or hit another sell signal. Yet a lot of them have rallied back and reclaimed their buy points....
AKRX: 43.14 (-0.40), ALXN: 190.49 (-1.71), CELG: 105.14 (-0.56)
Celgene Rises 2.83% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 24, 3:42PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $99.21 to a high of $103.31. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $100.91 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 105.14 (-0.56)
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed
at The Street - 1 hr ago
With the Federal Reserve finally ending its bond buying, there are many stocks that are ready to be bought, not sold, on any Fed-induced weakness, Cramer says.
KMI: 38.33 (-0.84), ETN: 65.92 (+1.14), FB: 75.86 (-4.91), PFE: 29.49 (+0.40), INVN: 16.08 (-5.40), WDC: 95.79 (+2.71), HPQ: 35.38 (-0.16), CVRR: 24.51 (-0.31), CELG: 105.14 (-0.56), EPB: 40.36 (-0.86), ISIS: 45.01 (-1.42), IBM: 163.46 (-0.14), AMAT: 21.47 (+0.22), GOOGL: 558.45 (-0.49), TWTR: 42.08 (-1.70), MSFT: 46.62 (+0.13), IGT: 16.29 (unch), REGN: 387.70 (-10.19), PII: 148.31 (-1.26), BABA: 98.31 (-1.37)
Final Glance: Biotechnology companies
AP - Wed Oct 29, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Midday Glance: Biotechnology companies
AP - Wed Oct 29, 12:41PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 29, 11:28AM CDT
Quite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
BIIB: 315.06 (-2.97), CBST: 71.35 (-0.99), MDCO: 25.16 (-0.70), SRPT: 15.19 (+0.07), ALXN: 190.49 (-1.71), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Early Glance: Biotechnology companies
AP - Wed Oct 29, 9:53AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 2.54% Gain
Comtex SmarTrend(R) - Tue Oct 28, 3:59PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 105.14 (-0.56)
After Yesterday's Rally of 2.54% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 28, 3:58PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 105.14 (-0.56)
Stocks Extend Gains As Alibaba, Tesla Rally
at Investor's Business Daily - Tue Oct 28, 11:04AM CDT
Major averages extended their gains in late-morning trading amid earnings reports and a surprisingly strong consumer confidence reading. The Nasdaq rallied 1.2%, the S&P 500 gained 0.6% and the Dow was up 0.4%. Volume was tracking higher on the...
TSLA: 238.10 (-4.67), AMGN: 158.88 (+1.69), AAPL: 107.34 (+0.60), BABA: 98.31 (-1.37), CELG: 105.14 (-0.56)
Can Celgene Corporation Stock Motor to $150 Following Earnings?
Sean Williams, The Motley Fool - Motley Fool - Tue Oct 28, 7:03AM CDT
Just as the proverbial American worker stamps their time card on a daily basis and does their job, biotech giant Celgene continues to deliver for shareholders without fail. Last Thursday, Celgene dazzled investors yet again by reporting better...
OMED: 21.95 (-0.13), AGIO: 79.36 (-1.24), CELG: 105.14 (-0.56)
Amgen Beats Earnings Estimates, What's Next for AMGN? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Oct 27, 11:59PM CDT
Amgen had a solid beat on earnings, and AMGN stock was rising after hours.
GILD: 110.72 (-2.73), AMGN: 158.88 (+1.69), CELG: 105.14 (-0.56)
Four Biotechs Lead Health Care Stocks In Big Cap 20
at Investor's Business Daily - Mon Oct 27, 6:00PM CDT
Medical stocks are flexing their muscles in the latest Big Cap 20 list, as they've more than doubled in number from the prior week. Even though a few medical sectors make the cut, biotechs are well represented. The group earned the top ranking in...
VRX: 129.76 (-1.31), ALXN: 190.49 (-1.71), ILMN: 188.88 (-1.77), AMGN: 158.88 (+1.69), REGN: 387.70 (-10.19), CELG: 105.14 (-0.56)
Forget MannKind Corporation: 3 Better Stocks
Motley Fool Staff - Motley Fool - Mon Oct 27, 8:13AM CDT
Source: MannKind. A doubling of Americans diagnosed with diabetes over the coming decade may support demand for MannKind 's inhalable insulin Afrezza, but that doesn't necessarily mean that MannKind is biotech's best idea. We asked three of...
DXCM: 44.50 (+0.34), NVAX: 5.41 (-0.07), AGIO: 79.36 (-1.24), SNY: 45.22 (-2.85), MNKD: 6.07 (-0.11), CELG: 105.14 (-0.56)
3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
Todd Campbell, The Motley Fool - Motley Fool - Mon Oct 27, 7:03AM CDT
Source: Celgene. Gilead Sciences has captured investors' attention this year thanks to wildly impressive sales of its hepatitis C drug Sovaldi, but the company is by no means the only fast-growing big biotech out there. Gilead's bottom line...
MDVN: 99.55 (-1.63), JNJ: 105.56 (+0.77), BIIB: 315.06 (-2.97), GILD: 110.72 (-2.73), NVS: 91.31 (-1.04), CELG: 105.14 (-0.56)
IBD 50 Stocks Regain Buy Points
at Investor's Business Daily - Fri Oct 24, 5:54PM CDT
The IBD 50 has been the land of the second chance, as many stocks have rebounded from sell signals. In several cases, stocks triggered the 8% sell rule or hit another sell signal. Yet a lot of them have rallied back and reclaimed their buy points....
AKRX: 43.14 (-0.40), ALXN: 190.49 (-1.71), CELG: 105.14 (-0.56)
Celgene Rises 2.83% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 24, 3:42PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $99.21 to a high of $103.31. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $100.91 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 105.14 (-0.56)
